The Niacin and Niacinamide Market was valued at US$ 1.2 billion in 2021, and by 2032, it is expected to grow to US$ 2.5 billion. Demand in the market is predicted to grow at a high 5.2% CAGR during the projection period. (2022 to 2032). The usage of liquid niacinamide in the cosmetic and personal …
Category Archives: Healthcare Trends
Patient-Controlled Analgesia Pumps Market is projected to reach US$ 699.9 Million by 2032 at a 5.2% CAGR
The Patient-Controlled Analgesia Pumps Market is projected to generate US$ 421.9 million in 2022 and US$ 699.9 million by 2032, expanding at a CAGR of 5.2%. According to a new estimate by Future Market Insights, PCA pumps will command the market globally in 2021 with a share of around 75.5%. The market for patient-controlled analgesia …
Saudi Arabia Pharmaceutical Market is expected to flourish at a CAGR of 9.6% by 2032 | FMI Study
The global Saudi Arabia Pharmaceutical Market is expected to create a fantastic opportunity by exhibiting an impressive CAGR of 9.6% from 2022 to 2032. By the end of 2022, the market is expected to be worth US$ 5,209.5 million. Saudi Arabia’s pharmaceutical market is expected to expand further over the forecast period, owing to the …
Aromatherapy Market is expected to reach a valuation of US$ 12.9 Billion by 2032 | FMI Study
The global Aromatherapy Market is predicted to grow with a positive outlook by exhibiting growth at a CAGR of 8.1% over the projection period from 2022 to 2032. The global market is expected to be valued at around US$ 5.9 Billion in 2022 with a total estimation of around US$ 12.9 Billion by 2032. Aromatherapy …
Oral Solid Dosage Pharmaceutical Formulation Market is expected to reach US$ 1.0 Billion at a CAGR of 6.4% by 2032 | FMI
Demand for the global Oral Solid Dosage Pharmaceutical Formulation Market is expected to grow at a healthy CAGR of 6.4% from 2022 to 2032. The global market is expected to reach US$ 555.3 million by 2022 and US$ 1.0 billion by 2032. According to studies, the tablets segment led the market in terms of dosage …
USA Ambulatory Surgical Centers Market is projected to attain a market value of US$ 73.5 billion by 2033 | FMI
The global Ambulatory Surgical Centers Market is expected to reach US$ 150.6 billion by 2033, growing at a CAGR of 4.5% during the forecast period. The proliferation of ambulatory surgical centers is surging on account of accelerating demand for inpatient as well as outpatient care services. The escalating costs of healthcare at general hospitals have …
Counterfeit Drug Detection Device Market is expected to reach US$ 1.56 Billion by 2029, with sales revenue expected to register 4.0% CAGR
The Counterfeit Drug Detection Device Market is predicted to develop significantly at a 4.0% CAGR during the forecast period. According to Future Market Insights, the sales of counterfeit drug detection devices are likely to account for US$ 1.14 Billion in 2022 and surpass US$ 1.56 Billion by 2029. The development initiatives launched by government agencies …
United States is projected to lead the global Dialysis Equipment Market by 2032 | FMI Study
The global Dialysis Equipment Market is expected to be worth US$ 17,871.8 million in 2022, rising to US$ 23,629.2 million by 2032. From 2022 to 2032, sales of dialysis equipment are expected to increase at a CAGR of 4.8%. The growing need for advanced dialysis equipment is highlighted due to the rising incidences of diabetes …
Retail Clinics Market is anticipated to hold a net worth of US$ 8.05 Billion by 2028 | FMI Report
The global Retail Clinics Market is expected to grow at a 9.6% CAGR from 2022 to 2028, with a current market valuation of US$ 4.64 billion and a projected market valuation of US$ 8.05 billion by the end of 2028. The retail clinics market has a maximum revenue contribution of 37.4% to the global supply chain management …
HIV/HBV/HCV Test Kits Market is expected to surpass US$ 11,53.9 million at a CAGR of 5.8% by 2033 | FMI Study
The HIV/HBV/HCV Test Kits Market is expected to be worth US$ 6,568.3 million in 2023, rising to US$ 11,573.9 million by 2033. During the forecast period, sales of HIV/HBV/HCV test kits are expected to grow at a significant CAGR of 5.8%. The global incidence of HIV and hepatitis has increased significantly, and this is expected …